Clinical phenotypes are essential for personalized medicine. They help in classifying cancers into subtypes, which can significantly influence treatment decisions. For example, the presence of the HER2 protein in breast cancer cells indicates that the patient may benefit from targeted therapies like trastuzumab. Similarly, the identification of specific mutations in lung cancer can guide the use of targeted therapies such as EGFR inhibitors.
